BrightSpring Health Services (NASDAQ:BTSG) CFO Sells 35,000 Shares

BrightSpring Health Services, Inc. (NASDAQ:BTSG) CFO Jennifer Phipps sold 35,000 shares of BrightSpring Health Services stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total value of $1,440,250.00. Following the sale, the chief financial officer owned 196,840 shares of the company’s stock, valued at approximately $8,099,966. This represents a 15.10% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

BrightSpring Health Services Trading Down 0.7%

NASDAQ:BTSG traded down $0.28 on Friday, reaching $41.49. The stock had a trading volume of 2,574,425 shares, compared to its average volume of 2,775,998. BrightSpring Health Services, Inc. has a 12-month low of $15.48 and a 12-month high of $44.87. The company has a market cap of $8.03 billion, a price-to-earnings ratio of 40.16, a P/E/G ratio of 0.55 and a beta of 2.31. The firm’s fifty day moving average is $39.50 and its two-hundred day moving average is $33.91. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.57 and a quick ratio of 1.12.

BrightSpring Health Services (NASDAQ:BTSG) last issued its quarterly earnings results on Friday, February 27th. The company reported $0.33 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.01). The firm had revenue of $3.55 billion for the quarter, compared to analysts’ expectations of $3.38 billion. BrightSpring Health Services had a return on equity of 12.66% and a net margin of 1.48%.The business’s quarterly revenue was up 29.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.11 earnings per share. Equities analysts expect that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

Institutional Investors Weigh In On BrightSpring Health Services

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in BrightSpring Health Services by 30.5% during the fourth quarter. Vanguard Group Inc. now owns 12,533,656 shares of the company’s stock worth $469,385,000 after acquiring an additional 2,928,953 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of BrightSpring Health Services by 4.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,662,236 shares of the company’s stock valued at $399,302,000 after purchasing an additional 478,436 shares in the last quarter. Invesco Ltd. grew its holdings in shares of BrightSpring Health Services by 13.4% during the 4th quarter. Invesco Ltd. now owns 10,595,232 shares of the company’s stock worth $396,791,000 after purchasing an additional 1,248,107 shares during the period. T. Rowe Price Investment Management Inc. increased its position in BrightSpring Health Services by 21.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,123,865 shares of the company’s stock worth $229,339,000 after purchasing an additional 1,091,757 shares in the last quarter. Finally, Alliancebernstein L.P. raised its holdings in BrightSpring Health Services by 12.1% in the second quarter. Alliancebernstein L.P. now owns 5,450,085 shares of the company’s stock valued at $128,568,000 after buying an additional 588,642 shares during the period.

Trending Headlines about BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Zacks added BTSG to its Zacks Rank #1 (Strong Buy) growth list for March 6, highlighting it as a top growth pick. Best Growth Stocks to Buy for March 6th
• Positive Sentiment: Zacks similarly featured BTSG on its March 5 list of best growth / strong-buy stocks, reinforcing buy-side attention across consecutive days. Best Growth Stocks to Buy for March 5th
• Positive Sentiment: Zacks upgraded BTSG from Hold to Strong Buy and published follow-ups pointing to momentum and rising earnings estimate revisions—signals that analysts are lifting near‑term expectations. Zacks.com upgrade
• Positive Sentiment: Zacks published a piece noting surging earnings estimate revisions for BTSG, which is commonly bullish for the stock if revisions translate into higher forward EPS and investor expectations. Surging Earnings Estimates Signal Upside
• Positive Sentiment: Broker commentary (Mizuho) and media noted strong price-appreciation forecasts and heavy trading after the analyst upgrade, which can support further upside if momentum continues. Mizuho Forecasts Strong Price Appreciation Sees Strong Trading Volume After Analyst Upgrade
• Neutral Sentiment: Zacks published comparative coverage showing how BTSG stacks up vs. medical peers this year—useful context but not an immediate catalyst. Peer Performance
• Neutral Sentiment: Reported short-interest figures in the dataset show 0 shares and 0.0 days-to-cover (likely a data artifact). That suggests no clear short-position signal from the reported data and should be treated cautiously.
• Negative Sentiment: Fundamentals remain mixed: the company’s most recent quarterly report showed strong revenue growth but a small EPS miss and the stock trades at a elevated PE, which can make it vulnerable to short-term pullbacks despite positive analyst notes.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Wells Fargo & Company raised their price objective on BrightSpring Health Services from $43.00 to $50.00 and gave the stock an “overweight” rating in a report on Monday. Stephens initiated coverage on BrightSpring Health Services in a research report on Wednesday, December 10th. They set an “overweight” rating and a $44.00 target price on the stock. KeyCorp raised BrightSpring Health Services from a “sector weight” rating to an “overweight” rating and set a $45.00 price target on the stock in a research note on Friday, December 12th. CJS Securities upgraded BrightSpring Health Services to a “strong-buy” rating in a report on Thursday, December 11th. Finally, BMO Capital Markets reiterated an “outperform” rating and set a $46.00 price objective on shares of BrightSpring Health Services in a report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $44.08.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.